We wish to inform you that, at the 37th Annual General Meeting ('AGM") held on 03rd September, 2025, the Shareholders of the Company have approved subject to the in principle approval by ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.6 pts more than Nifty Microcap 250 and 1.7 pts more than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
At the 37th AGM held on September 3, 2025, shareholders of Shree Pacetronix Ltd approved a preferential issue to a single allottee, Akash Sethi, who is one of the company's Promoters and Joint Managing Director. The issue comprises 75,150 equity shares at Rs. 81 each (total ~Rs. 60.87 lakh) along with 75,150 Series A warrants and up to 1,50,300 Series B warrants, each convertible into one equity share at Rs. 81 per share. If all warrants are fully exercised, the total value reaches about Rs. 2.43 crore and Akash Sethi's stake would rise from 0.35% (12,699 shares) to about 8.0% (3,13,299 shares). The company categorised this as not a related party transaction, though the allottee is a promoter and director.
Existing shareholders face dilution of up to about 7.65% if all warrants are converted; meanwhile, promoter Akash Sethi's stake will significantly increase, signalling the promoter's confidence in funding the company's growth through fresh capital.